Administrator on how pandemic has affected milestone events—the so-called “biodollars”—in life sciences’ deal structures
Casey McTigue, managing director of professional services at SRS Acquiom, which provides support for M&A transactions across various sectors, discusses the firm’s recently released study on milestone payment and earnout trends in life sciences M&A, including during Covid; their influence on sales and development milestones; how parties account for transaction disputes; and the potentially shifting power dynamic in pharma dealmaking post-pandemic.
The latest episode of The Pharmaceutical Commerce Podcast is available directly on SoundCloud.
